中国临床研究2024,Vol.37Issue(9) :1323-1326.DOI:10.13429/j.cnki.cjcr.2024.09.003

T细胞在结直肠癌中的作用及相关治疗进展

Advances in the role of T cells in colorectal cancer and related therapies

李月天 黄海宁 陈帅 王全义
中国临床研究2024,Vol.37Issue(9) :1323-1326.DOI:10.13429/j.cnki.cjcr.2024.09.003

T细胞在结直肠癌中的作用及相关治疗进展

Advances in the role of T cells in colorectal cancer and related therapies

李月天 1黄海宁 2陈帅 3王全义3
扫码查看

作者信息

  • 1. 济宁医学院临床医学院,山东济宁 272067
  • 2. 济宁医学院附属医院临床药学科,山东济宁 272029
  • 3. 济宁医学院附属医院病理科,山东济宁 272029
  • 折叠

摘要

T细胞与肿瘤的发生发展及肿瘤微环境(TME)稳态密切相关.其表面免疫检查点共受体共同调节着免疫应答.它可通过分泌各种物质抑制或杀伤肿瘤细胞,纠正和恢复受损的抗肿瘤免疫反应.近年来,靶向T细胞治疗获得一些进展,但一些新的免疫检查靶点仍在研究中.本文重点探讨T细胞在调控结直肠癌(CRC)和TME中的作用、CRC的免疫耐药机制及其靶向治疗等,论述T细胞对CRC发生发展的相关影响及靶向T细胞治疗CRC的应用前景.

Abstract

T cells are closely associated with tumor development and the homeostasis of the tumor microenvironment(TME).The co-receptors of immune checkpoints on the surface of T cells collectively regulate immune responses and can inhibit or kill tumor cells by secreting various substances,correcting and restoring impaired anti-tumor immune responses.In recent years,there has been some progress in targeted T cell therapy,but some new immune test targets are still being studied.This article focuses on the role of T cells in the regulation of colorectal cancer(CRC)and TME,the mechanism of immune resistance to CRC and its targeted therapy,and discusses the relevant effects of T cells on the occurrence and development of CRC and the application prospect of targeted T cell therapy for CRC.

关键词

结直肠癌/T细胞/肿瘤微环境/免疫治疗/免疫检查点抑制剂/过继细胞疗法/耐药

Key words

Colorectal cancer/T cells/Tumor microenvironment/Immunotherapy/Immune checkpoint inhibitors/Adoptive cell therapy/Drug resistance

引用本文复制引用

基金项目

济宁市重点研发计划项目(2023YXNS062)

济宁医学院高层次科研项目培育计划项目(JYGC2022FKJ014)

出版年

2024
中国临床研究
中华预防医学会

中国临床研究

CSTPCD
影响因子:0.943
ISSN:1674-8182
参考文献量2
段落导航相关论文